scispace - formally typeset
P

Per Venge

Researcher at Uppsala University

Publications -  457
Citations -  34544

Per Venge is an academic researcher from Uppsala University. The author has contributed to research in topics: Eosinophil cationic protein & Eosinophil. The author has an hindex of 86, co-authored 454 publications receiving 33109 citations. Previous affiliations of Per Venge include University of Helsinki & Karolinska Institutet.

Papers
More filters
Journal ArticleDOI

Bronchial biopsy findings in intermittent or "early" asthma.

TL;DR: Data show that inflammation is present in the airways of patients with early asthma, and the increase in tenascin expression in the basement membrane zone suggests that structural changes are also initiated at an early stage of the disease.
Journal ArticleDOI

The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X.

TL;DR: Measurement of blood eosinophils, s‐ECP, and s‐EPX indicated that salmeterol may modify this inflammatory cell activity, because raised s‐levels of ECP and EPX may be linked to eos inophil activation and granule secretion.
Journal ArticleDOI

Human neutrophil lipocalin (HNL) as a diagnostic tool in children with acute infections: a study of the kinetics

TL;DR: Both CRP and HNL were significantly raised at admittance in bacterial infection as compared to viral infection (p<0.001), and the levels of CRP, but not those of HNL, were significantly correlated to days of symptoms before admission.
Journal ArticleDOI

Evidence of eosinophil, neutrophil, and mast-cell mediators in the effusion of OME patients with and without atopy

TL;DR: This study was designed to measure the involvement of eosinophils, neutrophils, and mast cells in the middle ear of patients with OME and to see whether that inflammatory response differed depending on whether or not the patient was atopic.